Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Rebeca MejíasJ Lopez-Barneo

Abstract

Oxidative damage to dopaminergic nigrostriatal (DNS) neurons plays a central role in the pathogenesis of Parkinson's disease (PD). Glucose-6-phosphate dehydrogenase (G6PD) is a key cytoprotective enzyme that provides NADPH, the major source of the reducing equivalents of a cell. Mutations of this enzyme are the most common enzymopathies worldwide. We have studied in vivo the role of G6PD overexpressed specifically in the DNS pathway and show that the increase of G6PD activity in the soma and axon terminals of DNS neurons, separately from other neurons or glial cells, protects them from parkinsonism. Analysis of DNS neurons by histological, neurochemical, and functional methods showed that even a moderate increase of G6PD activity rendered transgenic mice more resistant than control littermates to the toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The neuroprotective action of G6PD was also observed in aged animals despite that they had a greater susceptibility to MPTP. Therefore, overexpression of G6PD in dopaminergic neurons or pharmacological activation of the native enzyme should be considered as potential therapeutic strategies to PD.

Citations

Jan 22, 2009·Journal of Neurology·Lin GaoJosé López-Barneo
Jun 10, 2008·Nature Neuroscience·Alberto PascualJosé López-Barneo
Sep 15, 2010·Proceedings of the National Academy of Sciences of the United States of America·Andrei G VlassenkoMark A Mintun
Dec 8, 2011·Antioxidants & Redox Signaling·Diane E Handy, Joseph Loscalzo
Mar 1, 2012·Antioxidants & Redox Signaling·Aracely Garcia-GarciaRodrigo Franco
Dec 18, 2013·Pharmacology & Therapeutics·Juliana Navarro-YepesRodrigo Franco
Oct 27, 2015·Journal of Neurochemistry·Ana B Muñoz-ManchadoJuan J Toledo-Aral
Feb 9, 2016·Clinical and Translational Imaging : Reviews in Nuclear Medicine and Molecular Imaging·Andrei G Vlassenko, Marcus E Raichle
Apr 20, 2016·Free Radical Biology & Medicine·Raquel Requejo-Aguilar, Juan P Bolaños
Jun 30, 2012·Neurobiology of Aging·Ana B Muñoz-ManchadoJuan J Toledo-Aral
Jun 6, 2012·Oxidative Medicine and Cellular Longevity·Philip Y Lam, Kam Ming Ko
May 28, 2019·Journal of Cellular Biochemistry·Bor Luen Tang
Sep 22, 2020·Brain Communications·Daniel Enterría-MoralesXavier d'Anglemont de Tassigny
May 31, 2018·Journal of Neuro-oncology·Chin-An YangJan-Gowth Chang
Jan 30, 2021·Acta Pharmacologica Sinica·Jie TangRui Sheng
Feb 17, 2021·Neurochemical Research·Zhe ZhangShinghua Ding
May 18, 2021·Frontiers in Neuroscience·Xin ZhangLiqin Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.